| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/14660820510027035 |
| P698 | PubMed publication ID | 16036424 |
| P2093 | author name string | Lacomblez L | |
| Meininger V | |||
| Bensimon G | |||
| Dib M | |||
| Garcia-Acosta S | |||
| Paillisse C | |||
| P2860 | cites work | Survival prediction in amyotrophic lateral sclerosis | Q46072802 |
| Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. | Q55032889 | ||
| A New Depression Scale Designed to be Sensitive to Change | Q29614720 | ||
| Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis | Q43569621 | ||
| Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis | Q44025604 | ||
| Survival of patients with amyotrophic lateral sclerosis in 2 Danish counties | Q44891007 | ||
| P433 | issue | 1 | |
| P921 | main subject | amyotrophic lateral sclerosis | Q206901 |
| P304 | page(s) | 37-44 | |
| P577 | publication date | 2005-03-01 | |
| P1433 | published in | Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | Q27714924 |
| P1476 | title | Prognostic factors for survival in amyotrophic lateral sclerosis patients treated with riluzole | |
| P478 | volume | 6 |
| Q58271878 | A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS |
| Q40770831 | A preliminary randomized trial of the mechanical insufflator-exsufflator versus breath-stacking technique in patients with amyotrophic lateral sclerosis. |
| Q30488423 | Amyotrophic Lateral Sclerosis Survival Score (ALS-SS): A simple scoring system for early prediction of patient survival |
| Q45388884 | An exploratory study of serum creatinine levels in patients with amyotrophic lateral sclerosis |
| Q38219475 | Assessment of disease progression and functional benefit in neurodegenerative disease: can we tell the difference? |
| Q28384807 | Association of lead exposure with survival in amyotrophic lateral sclerosis |
| Q33523900 | Association of smoking with amyotrophic lateral sclerosis risk and survival in men and women: a prospective study |
| Q40814817 | Biological follow-up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosis. |
| Q37523903 | Biomarkers in amyotrophic lateral sclerosis: facts and future horizons |
| Q47666996 | Blood lead, bone turnover, and survival in amyotrophic lateral sclerosis |
| Q82029198 | Chapter 13 Amyotrophic lateral sclerosis |
| Q35501852 | Clinical Measures of Disease Progression in Amyotrophic Lateral Sclerosis |
| Q55443790 | Clinical Staging of Amyotrophic Lateral Sclerosis in Chinese Patients. |
| Q38260277 | Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved? |
| Q47661601 | Comparison of slow and forced vital capacities on ability to predict survival in ALS. |
| Q35258218 | Coordinated care affects hospitalization and prognosis in amyotrophic lateral sclerosis: a cohort study |
| Q50914238 | Creatine kinase enzyme level correlates positively with serum creatinine and lean body mass, and is a prognostic factor for survival in amyotrophic lateral sclerosis. |
| Q36768040 | Depression and anxiety in individuals with amyotrophic lateral sclerosis: epidemiology and management |
| Q51721412 | Evidence of an environmental effect on survival in ALS. |
| Q38780389 | Factors to consider for motor neurone disease carer intervention research: A narrative literature review |
| Q37938694 | How can we improve clinical trials in amyotrophic lateral sclerosis? |
| Q33914518 | Iron metabolism disturbance in a French cohort of ALS patients |
| Q94326055 | Mechanical cough augmentation techniques in amyotrophic lateral sclerosis/motor neuron disease |
| Q91867885 | Metabolic Alteration and Amyotrophic Lateral Sclerosis Outcome: A Systematic Review |
| Q23915088 | Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiology and survival |
| Q47688852 | Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials |
| Q47222540 | Neuronal apoptosis inhibitory protein is implicated in amyotrophic lateral sclerosis symptoms |
| Q51071299 | Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics. |
| Q28748875 | Platelet Serotonin Level Predicts Survival in Amyotrophic Lateral Sclerosis |
| Q35747193 | Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm |
| Q60046685 | Prognostic Nomogram Associated with Longer Survival in Amyotrophic Lateral Sclerosis Patients |
| Q36447824 | Prognostic factors in ALS: A critical review |
| Q64087660 | SVC Is a Marker of Respiratory Decline Function, Similar to FVC, in Patients With ALS |
| Q47722450 | Safety and Efficacy of Nanocurcumin as Add-On Therapy to Riluzole in Patients With Amyotrophic Lateral Sclerosis: A Pilot Randomized Clinical Trial. |
| Q34375695 | Survival analysis of irish amyotrophic lateral sclerosis patients diagnosed from 1995-2010. |
| Q28651661 | The PRO-ACT database: design, initial analyses, and predictive features |
| Q50746593 | The impact of active coping strategies on survival in ALS: the first pilot study. |
| Q38014082 | The natural history of motor neuron disease: assessing the impact of specialist care |
| Q50161461 | The need for support services for family carers of people with motor neurone disease (MND): views of current and former family caregivers a qualitative study |
| Q37326016 | Underlying cause and place of death among patients with amyotrophic lateral sclerosis in Taiwan: a population-based study, 2003-2008. |
| Q48149243 | Using Eulerian video magnification to enhance detection of fasciculations in people with amyotrophic lateral sclerosis |
Search more.